3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
CNS
10
Sarcoma
3
Other solid neoplasm
1
Genitourinary
1
Conditions
Mesothelioma, Malignant
13
Retinoblastoma
9
Mesothelioma
9
Solid Tumor
7
Sarcoma
6
Pancreatic Neoplasms
6
Lung Neoplasms
6
Unspecified Childhood Solid Tumor, Protocol Specific
5
Unspecified Adult Solid Tumor, Protocol Specific
5
Solid Tumors
5
Carcinoma, Non-Small-Cell Lung
5
Ovarian Neoplasms
4
Wilms Tumor
3
Solid Tumor, Adult
3
Neuroblastoma
3
Colorectal Neoplasms
3
Advanced Solid Tumors
3
Advanced Solid Tumor
3
Thymoma
2
Stomach Neoplasms
2
Sarcoma, Ewing
2
Rhabdomyosarcoma
2
Osteosarcoma
2
Neoplasms
2
Neoplasm Metastasis
2
Kidney Neoplasms
2
Colonic Neoplasms
2
Cholangiocarcinoma
2
Carcinoma, Renal Cell
2
Breast Neoplasms
2
Interventions
omburtamab I-131
1
entinostat
1
Thalidomide
1
Nivolumab
1
Immunologic Techniques
1
Fentanyl
1
Erlotinib Hydrochloride
1
Cyclophosphamide
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Neuroectodermal Tumors, Primitive
×
Cyclophosphamide
×
Other solid neoplasm
×
Clear all
NCT01661400
2024-01-31
ASCR
Washington University School of Medicine
Phase 1
Completed
14 enrolled